Improved pharmacokinetics and reduced side effects of doxorubicin therapy by liposomal co-encapsulation with curcumin-Reference-Cited by-同舟云学术

Improved pharmacokinetics and reduced side effects of doxorubicin therapy by liposomal co-encapsulation with curcumin

Published:2019-11-12 Issue:1 Volume:31 Page:1-10
ISSN:0898-2104
Container-title:Journal of Liposome Research
language:en
Short-container-title:Journal of Liposome Research

Author:

Sesarman Alina¹²³,Muntean Dana³,Abrudan Bianca³,Tefas Lucia³,Sylvester Bianca³,Licarete Emilia¹²^ORCID,Rauca Valentin¹²,Luput Lavinia¹²^ORCID,Patras Laura¹²^ORCID,Banciu Manuela¹²,Vlase Laurian³,Porfire Alina³

Affiliation:

1. Department of Molecular Biology and Biotechnology, Faculty of Biology and Geology, “Babes-Bolyai” University, Cluj-Napoca, Romania

2. Molecular Biology Centre, Institute for Interdisciplinary Research in Bio-Nano-Sciences, “Babes-Bolyai” University, Cluj-Napoca, Romania

3. Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/08982104.2019.1682604

Reference59 articles.

1. Unbedenklichkeitsaspekte bei der Anwendung von pegyliertem liposomalem Doxorubicin bei Krebspatienten

2. Hepatic extraction, metabolism and biliary excretion of doxorubicin in the isolated prefused rat liver

3. Investigation into the Role of Tumor-Associated Macrophages in the Antitumor Activity of Doxil

4. Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculature

5. Cardiac safety of liposomal anthracyclines

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing chemotherapeutic efficacy: Niosome‐encapsulated Dox‐Cis with MUC‐1 aptamer;Cancer Medicine;2024-08

2. Approaches for reducing chemo/radiation-induced cardiotoxicity by nanoparticles;Environmental Research;2024-03

3. Liposome-based curcumin delivery systems as cancer therapeutics;Curcumin-Based Nanomedicines as Cancer Therapeutics;2024

4. Chicken embryo model for in vivo acute toxicological and antitumor efficacy evaluation of lipid nanocarrier containing doxorubicin;International Journal of Pharmaceutics: X;2023-12

5. Nanoformulations of curcumin: An alliance for effective cancer therapeutics;Food Bioscience;2023-12